← Back to Search

Procedure

Robotic Surgery for Pediatric Procedures (SPARCS Trial)

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is between 6 - 21 years of age (weighing at least 15 kilograms)
Subject without previous treatment using a robotic surgery device
Must not have
Subject with uncorrected coagulopathy
Subject has clinical requirement for primary open operative procedure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to gather more information to ensure that the da Vinci Xi Surgical System is safe and works well when used on pediatric and adolescent patients. It will be a small study to see if the system

Who is the study for?
This trial is for pediatric and adolescent patients needing surgeries like gallbladder removal, hysterectomy, or lung surgery. It's not specified who can't join the trial, but typically those with conditions that could complicate surgery or recovery might be excluded.
What is being tested?
The da Vinci Xi Robotic Surgery System is being tested to see if it's safe and works well for various surgeries in young patients. This pilot study by Stanford University will initially assess its feasibility and effectiveness.
What are the potential side effects?
While specific side effects aren't listed, robotic surgeries may involve risks such as bleeding, infection, or complications related to anesthesia similar to traditional surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 6 and 21 years old and weigh at least 15 kilograms.
Select...
I have never been treated with robotic surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a bleeding disorder that hasn't been treated.
Select...
I need surgery as my main treatment.
Select...
I cannot undergo surgery or general anesthesia due to health risks.
Select...
I am in a very severe state of health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Subjects With Device-related Serious Adverse Events
Performance
Secondary study objectives
Pediatric Quality of Life Inventory (PedsQL) score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
Arm 2 will be performed after all patients in Arm 1 have completed their procedures and where additional preclinical performance testing is required, including: Bronchoplasty, Endoscopic Laryngeal/Pharyngeal Suturing, including: Vocal Feminization, Laryngeal Cleft Repair, Endolaryngeal Adjacent Tissue Transfer, Pharyngoplasty; Ileocolonic Resections; Laryngoplasty with or without Graft; Proctectomy with Ileal Pouch-Anal Anastomosis (IPAA)
Group II: Arm 1Experimental Treatment1 Intervention
Arm 1 includes procedures to be performed robotically that have an adult model or already established preclinical evidence including: Sleeve Gastrectomy, Cholecystectomy, Splenectomy, Hysterectomy, endometriosis, ureteral re-implant, and cervical and thoracic tracheoplasty, thymectomy, lobectomy/wedge lung resection, lung segmentectomy

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,491 Previous Clinical Trials
17,517,914 Total Patients Enrolled
3 Trials studying Endometriosis
226 Patients Enrolled for Endometriosis
~167 spots leftby Feb 2027